
Keywords: CDC; Centers for Disease Control and Prevention; CLABSI; central line-associated bloodstream infections; CRBSI; catheter-related bloodstream infection; CVAD; central venous access device; FDA; US Food and Drug Administration; HL7 FHIR; Health Level 7 Fa